Correlation Between Johnson Johnson and Estrella Immunopharma
Can any of the company-specific risk be diversified away by investing in both Johnson Johnson and Estrella Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Johnson Johnson and Estrella Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Johnson Johnson and Estrella Immunopharma, you can compare the effects of market volatilities on Johnson Johnson and Estrella Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Johnson Johnson with a short position of Estrella Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Johnson Johnson and Estrella Immunopharma.
Diversification Opportunities for Johnson Johnson and Estrella Immunopharma
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Johnson and Estrella is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Johnson Johnson and Estrella Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Estrella Immunopharma and Johnson Johnson is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Johnson Johnson are associated (or correlated) with Estrella Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Estrella Immunopharma has no effect on the direction of Johnson Johnson i.e., Johnson Johnson and Estrella Immunopharma go up and down completely randomly.
Pair Corralation between Johnson Johnson and Estrella Immunopharma
Considering the 90-day investment horizon Johnson Johnson is expected to under-perform the Estrella Immunopharma. But the stock apears to be less risky and, when comparing its historical volatility, Johnson Johnson is 8.92 times less risky than Estrella Immunopharma. The stock trades about -0.25 of its potential returns per unit of risk. The Estrella Immunopharma is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 97.00 in Estrella Immunopharma on September 14, 2024 and sell it today you would earn a total of 26.00 from holding Estrella Immunopharma or generate 26.8% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Johnson Johnson vs. Estrella Immunopharma
Performance |
Timeline |
Johnson Johnson |
Estrella Immunopharma |
Johnson Johnson and Estrella Immunopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Johnson Johnson and Estrella Immunopharma
The main advantage of trading using opposite Johnson Johnson and Estrella Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Johnson Johnson position performs unexpectedly, Estrella Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Estrella Immunopharma will offset losses from the drop in Estrella Immunopharma's long position.Johnson Johnson vs. Emergent Biosolutions | Johnson Johnson vs. Bausch Health Companies | Johnson Johnson vs. Neurocrine Biosciences | Johnson Johnson vs. Teva Pharma Industries |
Estrella Immunopharma vs. Puma Biotechnology | Estrella Immunopharma vs. Iovance Biotherapeutics | Estrella Immunopharma vs. Day One Biopharmaceuticals | Estrella Immunopharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Equity Valuation Check real value of public entities based on technical and fundamental data |